Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 4 boards, counting each seat separately. Longest: Opus Genetics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Novavax Inc. June 18, 202660.4%
-
Ardelyx Inc. June 16, 202695.7%
-
Opus Genetics Inc. April 20, 202699.5%
-
Opus Genetics Inc. April 30, 202587.4%
-
Opus Genetics Inc. June 11, 202459.3%
-
Novavax Inc. July 11, 202369.9%
-
Ardelyx Inc. June 15, 202381.0%
-
Opus Genetics Inc. June 6, 202373.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 20, 2026 | Novavax Inc. | Option exercise | +18,880 | — | — |
| Jun 16, 2026 | Ardelyx Inc. | Grant or award | +26,455 | — | — |
| Apr 20, 2026 | Opus Genetics Inc. | Grant or award | +24,367 | — | — |
| Oct 29, 2025 | Novavax Inc. | Option exercise | +3,800 | — | — |
| Jun 18, 2025 | Ardelyx Inc. | Grant or award | +21,468 | — | — |
| Jun 18, 2025 | Ardelyx Inc. | Grant or award | +41,551 | — | — |
| Jun 12, 2025 | Novavax Inc. | Option exercise | +10,420 | — | — |
| Apr 30, 2025 | Opus Genetics Inc. | Grant or award | +79,504 | — | — |
| Jan 16, 2025 | Ardelyx Inc. | Option exercise | +100,000 | $0.55 | $55,000 |
| Oct 29, 2024 | Novavax Inc. | Option exercise | +3,800 | — | — |
| Jun 14, 2024 | Ardelyx Inc. | Grant or award | +12,204 | — | — |
| Jun 12, 2024 | Novavax Inc. | Option exercise | +6,670 | — | — |
| Jun 11, 2024 | Opus Genetics Inc. | Grant or award | +41,143 | — | — |
| Jan 1, 2024 | Opus Genetics Inc. | Grant or award | +24,762 | — | — |
| Nov 1, 2023 | Opus Genetics Inc. | Grant or award | +35,000 | — | — |
Questions about Richard J. Rodgers
What boards is Richard J. Rodgers on?
Richard J. Rodgers sits on the boards of Ardelyx Inc., Novavax Inc., Opus Genetics Inc. and Sagimet Biosciences Inc.
What company is Richard J. Rodgers the CEO of?
Richard J. Rodgers is Interim CEO and President of Opus Genetics Inc.
How long has Richard J. Rodgers served on boards?
Our records show at least 14 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.